P&G’s Intrinsa Priority Review Puts Approval Timeline At Early 2005
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Procter & Gamble’s testosterone patch Intrinsa could be approved for female sexual dysfunction by January.